Induction of the ABC-Transporters Mdr1/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during Establishment of Multidrug Resistance Following Exposure to Mitoxantrone-Reference-Cited by-同舟云学术

Induction of the ABC-Transporters Mdr1/P-gp (Abcb1), Mrp1 (Abcc1), and Bcrp (Abcg2) during Establishment of Multidrug Resistance Following Exposure to Mitoxantrone

Published:2005-04 Issue:2 Volume:17 Page:215-223
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

NIETH C.,LAGE H.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1179/joc.2005.17.2.215

Reference24 articles.

1. Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug

2. Rationale for the use of mitoxantrone in multiple sclerosis

3. Clinical applications of anticancer drugs targeted to topoisomerase II

4. Multidrug resistance in cancer: role of ATP–dependent transporters

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the functional role of clinical mutations in ABCB1, ABCC1, and ABCG2 ABC transporters in endometrial cancer;Frontiers in Pharmacology;2024-05-02

2. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies;Cancers;2023-11-02

3. The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells;Frontiers in Pharmacology;2023-07-13

4. Overcoming multidrug-resistant lung cancer by mitochondrial-associated ATP inhibition using nanodrugs;Journal of Nanobiotechnology;2023-01-12

5. Folate receptor-mediated delivery of mitoxantrone-loaded solid lipid nanoparticles to breast cancer cells;Biomedicine & Pharmacotherapy;2022-10